Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells

Cervantes-Madrid, D; Szydzik, J; Lind, DE; Borenas, M; Bemark, M; Cui, J; Palmer, RH; Hallberg, B

Palmer, RH; Hallberg, B (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.

SCIENTIFIC REPORTS, 2019; 9 ():